Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Dig Dis Sci ; 64(11): 3104-3114, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31127443

RESUMEN

BACKGROUND AND AIM: Simaba ferruginea A.St.-Hil. Popularly known as "calunga," is a typical Brazilian cerrado plant whose rhizomes are popular for treating diarrhea. AIMS: The aim of this study was to evaluate the spasmolytic activity and the antidiarrheal effect of the ethanolic extract obtained from S. ferruginea (Sf-EtOH). METHODS: Ileal segments (1-2 cm) from male Wistar rats were mounted in isolated organ baths and connected to a force transducer, and then to an amplifier which was connected to a computer (AVS Projetos/São Paulo-SP). After stabilization for 60 min, under tension (1 gf), two submaximal contractions were induced with KCl 40 mM or carbachol 10-6 M on ileal segments. During the third tonic and sustained contraction, Sf-EtOH was added in cumulative concentrations to the organ bath. Incubations with L-NAME (10-4 M), ODQ (10-5 M), TEA+ (5 or 1 mM), glibenclamide (10-5 M), or apamine (100 nM) were prepared (n = 5), separately and used to verify the involvement of the nitric oxide synthase, guanylate cyclase, and potassium channels in the relaxing effect. The results were expressed as mean ± standard error of the mean and were statistically evaluated using one-way ANOVA followed by Bonferroni test, when necessary *p < 0.05. RESULTS: Sf-EtOH promotes relaxation on rat isolated ileum pre-contracted with CCh and KCl in a concentration-dependent manner. Sf-EtOH also inhibited ileum contractions against cumulative concentrations of carbachol (CCh), KCl, and CaCl2, shifting the curves to the right in a non-parallel manner with an Emax reduction. In the presence of potassium channel blockers, Sf-EtOH shifted the curves to the right with a reduction of Emax, suggesting the involvement of BKCa, KATP, and SKCa in its spasmolytic effect. In the presence of L-NAME or ODQ, the relaxation curves were shifted to the right, suggesting the involvement of this pathway in Sf-EtOH spasmolytic effect. CONCLUSIONS: Sf-EtOH acts in a concentration-dependent manner, involving the positive modulation of K+ channels and NO pathway.


Asunto(s)
Guanilato Ciclasa/metabolismo , Íleon/metabolismo , Óxido Nítrico Sintasa/metabolismo , Parasimpatolíticos/farmacología , Canales de Potasio/metabolismo , Simaroubaceae , Animales , Relación Dosis-Respuesta a Droga , Íleon/efectos de los fármacos , Masculino , Relajantes Musculares Centrales/aislamiento & purificación , Relajantes Musculares Centrales/farmacología , Técnicas de Cultivo de Órganos , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta , Ratas , Ratas Wistar
2.
Biomed Chromatogr ; 31(1)2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27591736

RESUMEN

Baclofen is a commonly used racemic drug and has a simple chemical structure in terms of the presence of only one stereogenic center. Since the desirable pharmacological effect is in only one enantiomer, several possibilities exist for the other enantiomer for evaluation of the disposition of the racemic mixture of the drug. This calls for the development of enantioselective analytical methodology. This review summarizes and evaluates different methods of enantioseparation of (RS)-baclofen using both direct and indirect approaches, application of certain chiral reagents and chiral stationary phases (though very expensive). Methods of separation of diastereomers of (RS)-baclofen prepared with different chiral derivatizing reagents (under microwave irradiation at ease and in less time) on reversed-phase achiral columns or via a ligand exchange approach providing high-sensitivity detection by the relatively less expensive methods of TLC and HPLC are discussed. The methods may be helpful for determination of enantiomers in biological samples and in pharmaceutical formulations for control of enantiomeric purity and can be practiced both in analytical laboratories and industry for routine analysis and R&D activities.


Asunto(s)
Baclofeno/aislamiento & purificación , Cromatografía Líquida de Alta Presión/métodos , Agonistas de Receptores GABA-B/aislamiento & purificación , Relajantes Musculares Centrales/aislamiento & purificación , Baclofeno/química , Agonistas de Receptores GABA-B/química , Indicadores y Reactivos , Relajantes Musculares Centrales/química , Estereoisomerismo
3.
Biomed Chromatogr ; 30(11): 1728-1732, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27105592

RESUMEN

Separation of racemic mixture of (RS)-bupropion, (RS)-baclofen and (RS)-etodolac, commonly marketed racemic drugs, has been achieved by modifying the conventional ligand exchange approach. The Cu(II) complexes were first prepared with a few l-amino acids, namely, l-proline, l-histidine, l-phenylalanine and l-tryptophan, and to these was introduced a mixture of the enantiomer pair of (RS)-bupropion, or (RS)-baclofen or (RS)-etodolac. As a result, formation of a pair of diastereomeric complexes occurred by 'chiral ligand exchange' via the competition between the chelating l-amino acid and each of the two enantiomers from a given pair. The diastereomeric mixture formed in the pre-column process was loaded onto HPLC column. Thus, both the phases during chromatographic separation process were achiral (i.e. neither the stationary phase had any chiral structural feature of its own nor did the mobile phase have any chiral additive). Separation of diastereomers was successful using a C18 column and a binary mixture of MeCN and TEAP buffer of pH 4.0 (60:40, v/v) as mobile phase at a flow rate of 1 mL/min and UV detection at 230 nm for (RS)-Bup, 220 nm for (RS)-Bac and 223 nm for (RS)-Etd. Baseline separation of the two enantiomers was obtained with a resolution of 6.63 in <15 min. Copyright © 2016 John Wiley & Sons, Ltd.


Asunto(s)
Antidepresivos de Segunda Generación/aislamiento & purificación , Baclofeno/aislamiento & purificación , Bupropión/aislamiento & purificación , Cromatografía Líquida de Alta Presión/métodos , Inhibidores de la Ciclooxigenasa 2/aislamiento & purificación , Etodolaco/aislamiento & purificación , Relajantes Musculares Centrales/aislamiento & purificación , Aminoácidos/química , Antidepresivos de Segunda Generación/química , Baclofeno/química , Bupropión/química , Complejos de Coordinación/química , Cobre/química , Inhibidores de la Ciclooxigenasa 2/química , Etodolaco/química , Ligandos , Relajantes Musculares Centrales/química , Estereoisomerismo
4.
Basic Clin Pharmacol Toxicol ; 118(1): 58-62, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26132090

RESUMEN

The essential oil of Alpinia zerumbet (EOAz) presents myorelaxant and antispasmodic actions on cardiac and smooth muscles. The aim of this study was to investigate the effect of EOAz on the skeletal muscle contraction in post-stroke spasticity. Fifteen adults with unilateral hemiparesis and spasticity resulting from stroke were submitted to surface electromyography readings of the gastrocnemius muscle, before and after 10 daily applications (dermal 0.05 mL per muscle belly) of EOAz. The healthy contralateral muscles without applying the oil were used as controls. The analysis showed that, in both lateral and medial gastrocnemius, the values of all studied variables (root mean square, maximum amplitude and median power frequency) were significantly decreased in pathological legs during muscle contraction (Wilcoxon test, p < 0.05). Moreover, spastic muscles presented different results before and after dermal application of EOAz: The mean values of root mean square and median power frequency were significantly increased in lateral and medial gastrocnemius, and also, the maximum amplitude increased in medial gastrocnemius (Mann-Whitney test, p < 0.05). The results suggest that EOAz acts in the skeletal spastic muscle contraction by promoting relaxation and improvement of the muscular performance. Thus, the EOAz can be useful for the clinical management of secondary effects in patients with cerebral vascular disease.


Asunto(s)
Alpinia/química , Relajantes Musculares Centrales/uso terapéutico , Músculo Esquelético/efectos de los fármacos , Aceites Volátiles/uso terapéutico , Espasmo/prevención & control , Accidente Cerebrovascular/complicaciones , Administración Cutánea , Adulto , Electromiografía , Femenino , Cromatografía de Gases y Espectrometría de Masas , Humanos , Masculino , Relajantes Musculares Centrales/administración & dosificación , Relajantes Musculares Centrales/aislamiento & purificación , Aceites Volátiles/administración & dosificación , Aceites Volátiles/aislamiento & purificación , Hojas de la Planta/química , Espasmo/etiología
5.
Xenobiotica ; 41(9): 758-63, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21623702

RESUMEN

Eperisone, 4-ethyl-2-methyl-3-piperidinopropiophenone, is a centrally acting muscle relaxant widely used to relieve muscle stiffness and back pain. In this study, enantioselectivity for carbonyl reduction of eperisone was investigated in human liver microsomes, and the enzymes involved in the carbonyl reduction were characterised. Carbonyl reduction of eperisone predominantly occurred in microsomal fractions and 11ß-hydroxysteroid dehydrogenase type 1(11ß-HSD 1) played a major role in this reaction as judged by selective inhibition of the activity by BVT-14225 and KR-66344. The kinetic study with (+)-S- and (-)-R-eperisone showed that the formation of the carbonyl reduced metabolite (M5) from the (-)-R-isomer was more efficient than that from the (-)-S-isomer. As eperisone is a racemic compound with one chiral centre, the carbonyl reduced metabolite of eperisone (M5) may have four possible diastereoisomeric structures. Chiral separation of incubation mixtures of racemic eperisone with human liver microsome revealed that (1S, 2S)-M5 and (1R, 2R)-M5 were generated specifically from (+)-S- and (-)-R-eperisone, respectively. Selective formation of anti-diastereomers was further confirmed by incubation of individual enantiomer with microsomes. Carbonyl reduction of eperisone by microsomal 11ß-HSD 1 may significantly contribute to the metabolic disposition of eperisone in human and (-)-R-isomer is preferentially reduced by this enzyme.


Asunto(s)
Carbono/metabolismo , Microsomas Hepáticos/metabolismo , Propiofenonas/química , Propiofenonas/metabolismo , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 1/antagonistas & inhibidores , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 1/metabolismo , Cromatografía Líquida de Alta Presión , Humanos , Cinética , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Relajantes Musculares Centrales/química , Relajantes Musculares Centrales/aislamiento & purificación , Relajantes Musculares Centrales/metabolismo , Oxidación-Reducción/efectos de los fármacos , Proadifeno/farmacología , Propiofenonas/aislamiento & purificación , Estereoisomerismo , Sulfonamidas/farmacología , Tiazoles/farmacología
6.
Mar Biotechnol (NY) ; 7(3): 142-62, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15776313

RESUMEN

Marine sponges have been considered as a gold mine during the past 50 years, with respect to the diversity of their secondary metabolites. The biological effects of new metabolites from sponges have been reported in hundreds of scientific papers, and they are reviewed here. Sponges have the potential to provide future drugs against important diseases, such as cancer, a range of viral diseases, malaria, and inflammations. Although the molecular mode of action of most metabolites is still unclear, for a substantial number of compounds the mechanisms by which they interfere with the pathogenesis of a wide range of diseases have been reported. This knowledge is one of the key factors necessary to transform bioactive compounds into medicines. Sponges produce a plethora of chemical compounds with widely varying carbon skeletons, which have been found to interfere with pathogenesis at many different points. The fact that a particular disease can be fought at different points increases the chance of developing selective drugs for specific targets.


Asunto(s)
Factores Biológicos/química , Factores Biológicos/aislamiento & purificación , Biología Marina , Poríferos/química , Animales , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Antiinflamatorios/química , Antiinflamatorios/aislamiento & purificación , Antifúngicos/química , Antifúngicos/aislamiento & purificación , Antimaláricos/química , Antimaláricos/aislamiento & purificación , Antineoplásicos/química , Antineoplásicos/aislamiento & purificación , Antivirales/química , Antivirales/aislamiento & purificación , Fármacos Cardiovasculares/química , Fármacos Cardiovasculares/aislamiento & purificación , Inmunosupresores/química , Inmunosupresores/aislamiento & purificación , Relajantes Musculares Centrales/química , Relajantes Musculares Centrales/aislamiento & purificación
7.
Chirality ; 12(10): 720-6, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11054830

RESUMEN

The stereochemistry of tolperisone, a chiral aryl-alkyl basic ketone was investigated by means of circular dichroism (CD) and ultraviolet (UV) spectroscopy. The unusually high optical activity of tolperisone hydrochloride in the n-->pi* region is interpreted by the presence of a chiral conformer in solution. For stereochemical reasons, the C = O group and the aromatic moiety lack coplanarity by forming an inherently dissymetric chromophore, of M helicity. Similar helicity prevails in the crystal phase, according to the solid-state CD spectrum of (-)-tolperisone HCl salt. The chirality rule proposed by Snatzke for nonplanar benzoyl chromophores predicts the absolute configuration of (-)-tolperisone hydrochloride to be R, in agreement with other alpha-methyl-beta-amino-ketones.


Asunto(s)
Relajantes Musculares Centrales/química , Tolperisona/química , Dicroismo Circular , Modelos Moleculares , Conformación Molecular , Estructura Molecular , Relajantes Musculares Centrales/aislamiento & purificación , Propiofenonas/química , Solventes , Espectrofotometría Ultravioleta , Estereoisomerismo , Tolperisona/aislamiento & purificación
8.
J Biol Chem ; 272(13): 8320-4, 1997 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-9079654

RESUMEN

Buthus martensi Karsch venom exhibits nitrergic action in rat anococcygeus muscle (ACM). We have purified a novel toxin, makatoxin I (MkTx I), which exhibits nitrergic action, to homogeneity from this venom by a combination of gel-filtration, cation-exchange chromatography, and reverse-phase chromatography. Its purity was assessed by capillary electrophoresis and mass spectrometry. Its molecular weight was found to be 7031.71 +/- 2.88 as calculated from electrospray mass spectrographic data. The complete amino acid sequence was elucidated by sequencing of reduced and S-pyridylethylated toxin and a carboxyl-terminal peptide, P55-64, generated by the cleavage of toxin with endoproteinase Lys-C. The complete sequence of MkTx I is GRDAYIADSENCTYTCALNPYCNDLCTKNGAKSGYCQWAGRYGNACWCIDLPDKVPIRISGSCR. This toxin is composed of 64 amino acid residues and contains 8 half-cystine residues. Structurally, MkTx I has high similarity to Bot I and Bot II when compared with toxins from other scorpion species. The effects of MkTx I on nitrergic responses were investigated using the rat isolated ACM mounted in Krebs solution (37 degrees C, 5% CO2 in O2). MkTx I (2 microg/ml) markedly relaxed the carbachol-precontracted ACM; the relaxation was inhibited by the stereoselective inhibitor of nitric oxide synthase, Nomega-nitro-L-arginine methyl ester (50 microM). Thus, MkTx I is the first alpha-toxin that can mediate nitrergic responses in the rat isolated ACM.


Asunto(s)
Relajantes Musculares Centrales/aislamiento & purificación , Óxido Nítrico/metabolismo , Venenos de Escorpión/química , Venenos de Escorpión/aislamiento & purificación , Secuencia de Aminoácidos , Animales , Cromatografía Líquida de Alta Presión , Espectrometría de Masas , Datos de Secuencia Molecular , Relajantes Musculares Centrales/farmacología , Ratas , Venenos de Escorpión/farmacología , Escorpiones
9.
Pharmacol Res Commun ; 20 Suppl 5: 23-6, 1988 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2907790

RESUMEN

Some terpenoids extracted from marine sponge: triacetylated disidein, 2-tetraprenyl benzoquinol and 4 hydroxy-3-tetraprenylbenzoic acid 2-polyprenyl benzoquinols, avarol and furospongin-1 were tested by multidimensional Irwin screening and with some tests for analgesic and muscle relaxant activity. The three prenylhydroquinols derivatives and avarol show a good analgesic activity and low toxicity.


Asunto(s)
Fármacos del Sistema Nervioso Central/farmacología , Cnidarios , Terpenos/farmacología , Analgésicos/aislamiento & purificación , Analgésicos/farmacología , Animales , Fármacos del Sistema Nervioso Central/aislamiento & purificación , Evaluación Preclínica de Medicamentos , Ratones , Relajantes Musculares Centrales/aislamiento & purificación , Relajantes Musculares Centrales/farmacología , Terpenos/aislamiento & purificación
10.
J Nat Prod ; 46(4): 572-5, 1983.
Artículo en Inglés | MEDLINE | ID: mdl-6631439

RESUMEN

The major quaternary alkaloid from Strychnos angolensis was isolated, and its structure was determined by its spectral data as 11-methoxy-macusine A. The alkaloid showed muscle-relaxant activity.


Asunto(s)
Alcaloides/farmacología , Relajantes Musculares Centrales , Plantas Medicinales/análisis , África , Alcaloides/aislamiento & purificación , Animales , Fenómenos Químicos , Química , Femenino , Técnicas In Vitro , Espectroscopía de Resonancia Magnética , Ratones , Relajantes Musculares Centrales/aislamiento & purificación , Ratas , Estricnina/análogos & derivados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA